Tel: 514–461–1300

Our team
  • Director of the Montreal Heart Institute Research Center

    Jean-Claude Tardif, MD is professor of medicine at the Montreal Heart Institute, where he also serves as a cardiologist and Director of the Research Center. Dr. Tardif graduated with a medical degree, from the University of Montreal in 1987 and completed his fellowship in cardiology in 1992. He then completed a research fellowship at the New England Medical Center, Tufts University in 1994. Returning to Montreal, he took up a position as cardiologist at the Heart Institute that same year, where he also holds the Canada Research Chair in translational and personalized medicine. Dr. Tardif also occupies the University of Montreal endowed research chair in atherosclerosis. Dr. Tardif has authored and co-authored more than 600 articles and abstracts in peer-reviewed publications including The New England Journal of Medicine, the Journal of the American Medical Association, the Lancet, Circulation, and the Journal of the American College of Cardiology. In addition, he has written more than 25 book chapters. He is the principal investigator and Steering Committee chair or member of several large international cardiovascular clinical trials.

  • Director, Montreal Health Innovations Coordinating Center (MHICC)

    Dr. Andreas Orfanos received his FFPM from the Royal College of Physicians of the United Kingdom and his MBBCh and MBA from the University of the Witwatersrand, South Africa.
    Dr. Orfanos has over 25 years of extensive international experience in strategy development, executive and operational management roles in major healthcare sectors, with a particular focus on global pharmaceuticals and biotechnology. Prior to joining the MHICC, Dr. Orfanos was Vice President at Thrasos Therapeutics. He also established ORFANOS Global Healthcare Consulting Inc., which focused on creating value for organizations through strategy development and the advancement of medical products and technologies. Dr. Orfanos was formerly Executive Vice President, Strategic Planning and Scientific Affairs at Neurochem. He also served at Picchio Pharma, Novartis Pharmaceuticals, Sandoz and Lifecare. He has held various lead roles in strategy development, business development, leadership of specialty business units, and in drug development and clinical management. He has been instrumental in several leading studies in the fields of transplantation, oncology, renal disease and cardiac surgery.